These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23880543)

  • 1. Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012.
    Kassab S; Saghi T; Boyer A; Lafon ME; Gruson D; Lina B; Fleury H; Schuffenecker I
    Emerg Infect Dis; 2013 Aug; 19(8):1345-7. PubMed ID: 23880543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lethal enterovirus myocarditis associated with rituximab and chemotherapy for follicular lymphoma].
    Alonso JJ; Cánovas A; Rubio G
    Med Clin (Barc); 2013 Nov; 141(10):459-60. PubMed ID: 23622890
    [No Abstract]   [Full Text] [Related]  

  • 3. Enterovirus 71 meningoencephalitis complicating rituximab therapy.
    Ahmed R; Buckland M; Davies L; Halmagyi GM; Rogers SL; Oberste S; Barnett MH
    J Neurol Sci; 2011 Jun; 305(1-2):149-51. PubMed ID: 21444094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance rituximab should be considered for patients with follicular lymphoma.
    Barr PM
    Clin Adv Hematol Oncol; 2014 Aug; 12(8):541-3. PubMed ID: 25356579
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe anemia during rituximab maintenance therapy for follicular lymphoma.
    Liapis K; Harhalakis N; Stefanou G; Apostolidis J
    J Clin Oncol; 2012 Mar; 30(8):e95-6. PubMed ID: 22231048
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab maintenance therapy for follicular lymphoma.
    Zhou H; Zhang B; Zhang J; Ni W; Hu Z
    Lancet; 2011 Apr; 377(9772):1150-1; author reply 1151-2. PubMed ID: 21459204
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy.
    Heger JM; Eichenauer DA; Kasper P; Böll B; Shimabukuro-Vornhagen A; Kochanek M
    Eur J Haematol; 2019 Sep; 103(3):268-271. PubMed ID: 31211882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy.
    Ganjoo KN; Raman R; Sobel RA; Pinto HA
    Leuk Lymphoma; 2009 Apr; 50(4):673-5. PubMed ID: 19373672
    [No Abstract]   [Full Text] [Related]  

  • 9. Coxsackievirus A16 encephalitis during obinutuzumab therapy, Belgium, 2013.
    Eyckmans T; Wollants E; Janssens A; Schoemans H; Lagrou K; Wauters J; Maertens J
    Emerg Infect Dis; 2014 May; 20(5):913-5. PubMed ID: 24751368
    [No Abstract]   [Full Text] [Related]  

  • 10. A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas.
    Nabhan C; Ollberding NJ; Villines D; Chiu BC; Caces DB; Valdez TV; Ghielmini M; Hsu Schmitz SF; Smith SM
    Leuk Lymphoma; 2014 Jun; 55(6):1288-94. PubMed ID: 23998254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal Coxsackie meningoencephalitis in a patient with B-cell lymphopenia and hypogammaglobulinemia following rituximab therapy.
    Palacios T; Bartelt L; Scheld W; Lopes MB; Kelting SM; Holland S; Lipkin WI; Quan PL; Borish L; Lawrence M
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):148-50. PubMed ID: 26048250
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma.
    Rashidi A; Oak E; Bartlett NL
    Blood; 2015 May; 125(21):3354-5. PubMed ID: 25999445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Laboratory diagnosis for enterovirus 71 infection].
    Shimizu H
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():389-92. PubMed ID: 16111282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rituximab-induced interstitial lung disease].
    Fernández Casares M; Espósito G; González A; Segovia J; Galperín Mde L; Del Valle E
    Medicina (B Aires); 2013; 73(4):343-5. PubMed ID: 23924535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab.
    Schilthuizen C; Berenschot HW; Levin MD
    Neth J Med; 2010 May; 68(5):221-3. PubMed ID: 20508271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial.
    Ardeshna KM; Qian W; Smith P; Braganca N; Lowry L; Patrick P; Warden J; Stevens L; Pocock CF; Miall F; Cunningham D; Davies J; Jack A; Stephens R; Walewski J; Ferhanoglu B; Bradstock K; Linch DC
    Lancet Oncol; 2014 Apr; 15(4):424-35. PubMed ID: 24602760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of postremission therapy in follicular lymphoma: efficacy of rituximab maintenance.
    Roy R; Gordon LI
    J Natl Compr Canc Netw; 2011 May; 9(5):563-71. PubMed ID: 21550969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing immunosuppression and infection: recurrent enterovirus encephalitis in SLE.
    Cheema S; Bunting E; Good C; Hajela V; Ridha BH; Saha RA
    Pract Neurol; 2019 Dec; 19(6):508-510. PubMed ID: 31171649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials.
    Vidal L; Gafter-Gvili A; Salles G; Dreyling MH; Ghielmini M; Hsu Schmitz SF; Pettengell R; Witzens-Harig M; Shpilberg O
    J Natl Cancer Inst; 2011 Dec; 103(23):1799-806. PubMed ID: 22021664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany.
    Karrasch M; Fischer E; Scholten M; Sauerbrei A; Henke A; Renz DM; Mentzel HJ; Böer K; Böttcher S; Diedrich S; Krumbholz A; Zell R
    J Clin Virol; 2016 Nov; 84():90-95. PubMed ID: 27771495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.